Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
Status:
Terminated
Trial end date:
2018-05-19
Target enrollment:
Participant gender:
Summary
The primary objective of this study ist to test the hypothesis that ticagrelor is superior to
Aspirin (ASA) fort he prevention of major cardio- and cerebrovascular events (MACCE) in
patients undergoing artery bypass operation.
The primary efficiacy MACCE-endpoint is the composite of cardiovascular death, myocardial
infarction, recurent revascularisation, and stroke at twelve month after coronary artery
bypass operation.